Local Company to Offer Testing for Breast Cancer Gene

Pathway Genomics is preparing to offer the tests

By Chris Chan
|  Saturday, Jun 15, 2013  |  Updated 9:18 AM PDT
View Comments (
)
|
Email
|
Print
One local company is already preparing to offer a more affordable test to patients after the Supreme Court ended a patent on genetic testing for breast cancer.

One local company is already preparing to offer a more affordable test to patients after the Supreme Court ended a patent on genetic testing for breast cancer.

advertisement
Photos and Videos

Jolie's Uncle Advises Cancer Screenings

Less than two weeks after Angelina Jolie's double mastectomy, her aunt dies of breast cancer. Debbie Martin's husband Ron talks exclusively to NBC 7 San Diego about her battle with the deadly disease.

Dr. Snyderman Discusses Ovary Removal

NBC Chief Medical Editor Dr. Nancy Snyderman talks to Christine Haas about why Angelina Jolie is reportedly removing her ovaries.
More Photos and Videos

Advocates for breast cancer patients are ecstatic about the Supreme Court ruling that ended a patent on genetic screening tests for a breast cancer gene.

Now San Diego company Pathway Genomics is preparing to offer a more affordable test to patients.

Angelina Jolie tested positive for a genetic mutation that makes breast and ovarian cancer extremely likely. And after the Supreme Court ruled that DNA tests for those mutations cannot be patented, testing will get cheaper.

That's good news for cancer victim advocates who worry about women who are uninsured.

“These tests, these lifesaving tests will be much more affordable for all of us regardless of how much money is in your pocket.” said Laura Farmer Sherman from the Susan G. Komen chapter in San Diego.

The company Myriad Genetics held the patent for testing on what's called the BRCA1 and BRCA2 genes, and charged anywhere between $3,000-7,000.

After the Supreme Court ruling, local company Pathway Genomics announced that it will offer tests on those genes, and others will likely follow.

“It will result in other laboratories that have the capability of Pathway to offer these tests at a substantially lower price point,” said Jim Plante, the Pathway Genomics Founder and CEO.

Pathway Genomics would not say how much it will charge but promises it will be much less than $3,000.

With an estimated 40,000 people expected to die of breast cancer this year, Pathway Genomics hopes the effects of cheaper genetic testing will be profound.

“It could potentially save tens of thousands, if not hundreds of thousands of lives, said Plante.

Follow NBC 7 for the latest news, weather, and events: iPad App | iPhone App | Android App | Facebook | Twitter | Google+ | Instagram | RSS | Text Alerts | Email Alerts

Get the latest headlines sent to your inbox!
View Comments (
)
|
Email
|
Print
Leave Comments
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out